OH Beteiligungen

OH Beteiligungen GmbH & Co. KG is a German investment and holding company that serves as a primary vehicle for the life sciences investments of SAP co-founder Dietmar Hopp and his family. Based in Wiesloch, the firm specializes in providing long-term venture capital and strategic guidance to innovative biotechnology and medical technology companies. Its portfolio features significant holdings in prominent German biotech firms, most notably CureVac, which focuses on mRNA therapeutics, and Immatics, which specializes in cancer immunotherapies. The company also maintains interests in other healthcare entities such as AC Immune, Molecular Health, and Apogenix. OH Beteiligungen typically operates in close coordination with affiliated entities like dievini Hopp BioTech holding to support the development of transformative healthcare solutions from early-stage research through clinical commercialization.